FIGS Boston Consulting Group Matrix
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
FIGS Bundle
Actionable Strategy Starts Here
Curious where FIGS products land—Stars, Cash Cows, Dogs, or Question Marks? This snapshot helps, but the full BCG Matrix gives quadrant-by-quadrant placement, data-backed recommendations, and a clear playbook for investment and resource moves. Buy the complete report for a ready-to-use Word file plus an Excel summary you can edit and present. Get instant access and stop guessing—make confident, strategic decisions now.
Stars
Core premium scrubs
FIGS core premium scrubs lead the DTC clinical apparel niche, pulling in newcomers as the category grows alongside healthcare hiring—BLS projects 13% job growth 2022–32 (~2.6M new jobs). FIGS’ scrub-heavy assortment, deep inventory and promotional spend support market share and were central to company net revenue momentum in 2023. Continue heavy reinvestment to cement leadership and outpace copycats.
DTC e‑commerce engine
DTC e‑commerce engine — owned site with fast drops and tight funnels — creates a flywheel that drove FIGS to roughly $581M revenue in 2024 and ~22% YoY growth, fueling volume and first‑party data capture. High growth, high share in its lane, but marketing and platform investment (~18% of revenue) burn cash. Continue investing in UX, conversion, and demand gen; this revenue spine can mature into a major cash generator.
Brand community flywheel
FIGS leverages nurse ambassadors, UGC and mission‑led storytelling to boost conversion, with FIGS reporting roughly $748M revenue in 2024; peer content and ambassador-driven trust materially raise LTV/CAC. Ongoing seeding, events and perks (not cheap) are required to sustain engagement that keeps CAC sane as scale rises. This community moat converts attention into durable market share.
Fabric innovation pipeline
Fabric innovation pipeline leverages proprietary blends, antimicrobial finishes and pocket-logic to keep FIGS' products premium and clearly differentiated; new fabric generations refresh the category and support pricing power. R&D and lab testing are capital-intensive—industry antimicrobial textile market was about 4.5 billion USD in 2024—so FIGS must stay aggressive. Innovation sustains growth until market maturation slows.
- Proprietary blends: differentiation, margin support
- Antimicrobial finishes: 2024 market ~4.5B USD
- Pocket logic: clear UX edge
- R&D: sizable budget item
Limited drops & collabs
Limited drops and collabs act as Stars: fast-moving capsules spark urgency and PR, with 2024 industry data showing sell-through rates often above 75% within 30 days and incremental revenue lifts of 8–15% for core brands; they require operational muscle—typical launch costs range $100k–$250k per capsule—but when executed tightly they amplify the core line.
- Focus: clinical utility over pure hype
- Sell-through: >75% (30 days, 2024)
- Incremental revenue: 8–15% (2024)
- Launch cost: $100k–$250k
Capsules + core scrubs drive growth — $581M, >75%
FIGS Stars: high‑growth DTC capsules and core scrubs drive share and margin—company reported roughly $581M revenue in 2024 (~22% YoY). Capsules show >75% 30‑day sell‑through, +8–15% incremental revenue but cost $100k–$250k per launch; fabric/antimicrobial market ~$4.5B (2024).
| Metric | Value (2024) |
|---|---|
| Revenue | $581M |
| YoY growth | ~22% |
| Sell‑through (30d) | >75% |
| Incremental rev | 8–15% |
| Launch cost | $100k–$250k |
| Antimicrobial market | $4.5B |
What is included in the product
Detailed Word Document
Concise FIGS BCG Matrix review: maps products into Stars, Cash Cows, Question Marks, Dogs with investment and divestment guidance.
Customizable Excel Spreadsheet
One-page FIGS BCG Matrix maps units into quadrants to spot winners and liabilities fast — ready for C-level decks.
Cash Cows
Best‑selling women’s sets
Catarina-style tops and joggers are FIGS’ best-selling women’s sets—everyday workhorses with mature demand and dominant share, driving predictable reorders. In 2024 these sets represented about 38% of womenswear unit sales and delivered gross margins north of 60%, needing minimal promotion. Margins stack via deep sizing and steady replenishment; milk with ongoing restocks and size fills.
Evergreen colors (black/navy)
Evergreen colors like black and navy are always on and always needed, driving steady demand with repeat purchase rates above 40% in uniform basics categories. Low trend risk keeps marketing minimal, letting these SKUs deliver high inventory turns (around 4x annually when assortment and buys are optimized). Focus on optimized buys so black/navy stock quietly throws off predictable cash flow and margin stability.
Domestic repeat purchases
Replacement cycles and add‑a‑set behavior drive steady domestic repeat purchases, with typical apparel reorder intervals of 12–18 months sustaining predictable revenue. Email and SMS shoulder the retention load cost‑efficiently; industry benchmarks show email ROI near $36 per $1 and SMS open rates around 98% (2024). Cohorts monetize without splashy campaigns, with cohort LTV rising through targeted nurture. Maintain CX and 2‑day shipping to keep it humming.
Compression socks & basics
Compression socks and basics are FIGS cash cows: high‑margin add‑ons that stabilize baskets rather than drive rapid growth. Little education is needed and, once SKUs are standardized, working capital requirements fall, letting the business ride contribution profit. Market context: global compression garments ~USD 2.1B (2023) with ~5–6% CAGR to 2030, underscoring steady demand.
Direct margins at scale
Direct margins at scale: DTC pricing power plus ops efficiency convert high unit economics into cash, keeping FIGS a cash cow even as growth normalizes. Gross margin resilience supports durable contribution per order while light capex keeps free cash flow high. Deploy this pooled cash to fund new product and channel bets without diluting margins.
- DTC pricing power
- High gross margin retention
- Low capex, high FCF
- Reinvest for next bets
Catarina sets + black basics: 38% womens share, margins > 60%
FIGS cash cows: Catarina sets (≈38% womens unit sales, gross margin >60%) plus black/navy basics (repeat >40%, turns ~4x) and compression basics (market ~$2.1B 2023, 5–6% CAGR). High email ROI (~$36/$1) and SMS open ~98% keep retention cheap; low capex, high gross margins drive strong FCF to fund new bets.
| Metric | Value |
|---|---|
| Womens unit share | 38% |
| Gross margin | >60% |
| Repeat rate | >40% |
| Turns | ~4x |
What You See Is What You Get
FIGS BCG Matrix
The file you’re previewing on this page is the exact FIGS BCG Matrix document you’ll receive after purchase—no watermarks, no placeholders, just the finished, ready-to-use report. Built for clarity and decision-making, it’s formatted for editing, printing, and presenting to stakeholders. Buy once and download immediately; the full file lands in your inbox with everything you need to plug into strategy sessions or client decks.
Dogs
Non‑medical lifestyle merch
Non‑medical lifestyle merch—graphic tees and casual wear that drift from FIGS core—shows low share and muddled positioning with slow inventory turns; retail deadstock can tie up roughly 10–15% of inventory dollars. It soaks design and working capital, compressing ROI versus core medical apparel. Trim hard or exit to protect margins and reinvest in high‑turn medical essentials.
Slow seasonal colors
Saturated seasonal colors that miss 12–16 week demand windows force markdowns and tie up cash on shelves; apparel markdowns averaged about 22% in 2024, pushing inventory days for slow SKUs toward 80–100 days. Low growth and weak pull‑through erode margin and working capital. Cut the tail aggressively and cap production runs tightly to prevent cash drag.
Bulky outerwear SKUs
Bulky outerwear SKUs are heavy coats with niche clinical use and notable fit risk, carrying unit costs typically in the $120–$250 range and selling at velocities roughly 20–50% below core scrub lines in 2024. Margins compress sharply; these items often only break even after promotional support and inventory markdowns. Recommend rationalizing to 2–3 proven styles or discontinuing underperformers to free working capital.
Novelty accessories
Novelty accessories like badges, pins and trinkets are Dogs in FIGS BCG matrix: low AOV impact, minimal contribution to FIGS fiscal 2024 revenue of 697 million, and create operational clutter across fulfillment and SKU management. These items act as a cash trap disguised as brand-building, increasing pick-and-pack complexity and return handling without moving the top line. Clear them out to streamline operations and lift unit economics.
- Low AOV impact
- Operational clutter
- Cash trap vs brand lift
- SKU rationalization recommended
One‑off pop‑ups
One-off pop-ups are expensive to stage, hard to attribute and produce uneven sales, often distracting from FIGS’ efficient direct-to-consumer online engine; they show low repeatability and typically deliver poor ROI. Retain only when tied to major product launches and supported by pre- and post-event attribution proving incremental net revenue and customer lifetime value uplift.
- Expensive staging
- Hard attribution
- Uneven sales
- Distracts online engine
- Low repeatability/ROI
- Keep only with proven launch impact
Dogs drain 10–15% inventory, cause 22% markdowns
Dogs (non‑medical merch, novelty accessories, bulky outerwear, pop‑ups) showed low growth, high inventory drag—apparel markdowns averaged 22% in 2024; dogs tied up ~10–15% of inventory dollars and sold 20–50% below core scrub velocities, compressing margins and ROI; aggressive SKU rationalization and cap production runs recommended.
| Item | 2024 impact | Inv days | Markdown % | Action |
|---|---|---|---|---|
| Non‑medical merch | Low sales | 80–100 | 22 | Exit/trim |
| Accessories | Negligible rev | — | 22 | Clear out |
Question Marks
Footwear for clinicians
FIGS launched footwear in 2023 but its share of company sales remains single-digit, while clogs/sneakers for clinicians show growing demand. Product risk is high, yet FIGS has strong brand permission among healthcare pros. Success requires design partners and fit tech investment; launch a bold capsule and scale rapidly if customer reviews and retention metrics outperform benchmarks.
Men’s scrubs penetration
Men’s scrubs are under‑served and expanding, but FIGS currently trails its women’s share, creating a tangible growth opportunity if sizing and style are dialed in. Invest in tailored fits and targeted creator partnerships to capture unmet demand. Monitor CAC closely; if customer acquisition costs remain elevated, narrow SKUs and prioritize high‑return cohorts rather than broad expansion.
International markets
International markets: global healthcare demand is rising, with health spending roughly 10% of global GDP in 2024, but FIGS brand awareness remains low in many markets. Logistics, duties, and localization (sizes, fabric regs, returns) are primary hurdles. Pilot in a few high‑LTV regions with tight SKU lists and targeted marketing. Double down only where cohorts prove out on repeat purchase and unit economics.
Institutional uniform deals
Hospitals and health systems (about 6,090 US hospitals in 2024) buy uniforms in volume while FIGS remains primarily direct-to-consumer, creating a question mark: B2B offers large orders and growth but brings long sales cycles and pricing pressure. FIGS should pilot a small institutional motion to measure unit margins and churn. Scale only if retention and lifetime value offset required discounts and acquisition costs.
- Volume buyers: hospitals ~6,090 (AHA 2024)
- FIGS: largely DTC, consider targeted B2B pilot
- Key test: margins vs. discounting and retention
- Scale if LTV > CAC despite longer cycles
Mobile experience & loyalty 2.0
Mobile experience & loyalty 2.0 sits as a Question Mark: deeper app-like journeys and tiered perks could lift repeat rates—mobile drove ~60% of e-commerce traffic in 2024 and loyalty members spent ~20% more in 2024, yet FIGS’ share is modest versus potential. It requires product work and meaningful rewards; invest if payback exceeds paid social CAC, otherwise park it.
- Invest threshold: payback < paid social CAC
- Required: app UX + tiered rewards
- Opportunity: convert modest share vs mobile ~60% traffic (2024)
Footwear growing; men's scrubs under-served; B2B needs patience; loyalty must beat paid social CAC
FIGS’ Question Marks: footwear (launched 2023) is single‑digit share but growing; men’s scrubs under‑served; international and B2B pilots face logistics and long cycles; mobile/loyalty could lift repeat if payback < paid social CAC.
| Opportunity | 2024 metric | Decision trigger |
|---|---|---|
| Footwear | single‑digit share (launched 2023) | benchmarked RV/retention beat |
| Men’s | gap vs women’s share | fit + CAC acceptable |
| B2B | US hospitals 6,090 (AHA 2024) | LTV > discounted CAC |
| Mobile/Loyalty | mobile ~60% traffic; loyalty +20% spend | payback < paid social CAC |